September Roundup: The Latest in Automotive and Eye Health

Dive into our September roundup covering the automotive and eye health sectors. Learn about Ineos Grenadier's U.S. entry, Porsche's EV shift, and groundbreaking research in eye health. Our roundup offers a comprehensive look at the innovations and developments that are shaping the future.

By Liana Farrell
Sep 27, 2023
20 Minutes
September Roundup: The Latest in Automotive and Eye Health


As we wrap up September, it's time to take a look back at some of the most impactful stories in the realms of automotive advancements and eye health. From the much-anticipated arrival of the Ineos Grenadier in the U.S. to groundbreaking insights into macular degeneration, this month has been a whirlwind of innovation and discovery. Buckle up as we take you on a journey through the latest developments that are shaping the future of cars and vision care.

A Milestone for Ineos and Hambach

If you've been keeping an eye on the automotive world, you'll know that Ineos Automotive's Grenadier SUV has been generating quite the buzz. Well, the wait is almost over for American consumers. Ineos has officially announced that the first batch of these much-anticipated SUVs has left their production line in Hambach, France, and is headed for the U.S.

The first Grenadier to make the transatlantic journey is a special Belstaff Fieldmaster edition, adorned in a striking Scottish White exterior paint. This marks a significant milestone not just for Ineos Automotive but also for their Hambach plant. CEO Lynn Calder emphasized the importance of this moment, stating that the start of production for North American vehicles is a big deal for both the company and the plant. Over the past six months, they've been ramping up production rates to meet the high demand, especially from the U.S., which is their biggest market with an impressive 7,000 orders.

Multi-Million Dollar Investment

Ineos didn't just inherit the Hambach facility; they transformed it. After purchasing it from Mercedes over two years ago, they invested more than $53 million to revamp the factory. The upgrades included a fully-automated body shop, a semi-automated paint shop, and a new quality center. This investment underscores Ineos' commitment to delivering world-class quality SUVs.

Dealer Network and Future Plans

Before the Grenadiers touch down on American soil, Ineos plans to announce its official U.S. dealer network. According to Greg Clark, Ineos' Executive Vice President for the Americas, they've spent considerable time selecting an exceptional team of experienced dealers. By the time the first Grenadiers arrive, Ineos aims to have 35 dealerships across North America.

What's Next?

With deliveries expected to commence in November, American consumers won't have to wait much longer to get behind the wheel of a Grenadier. Meanwhile, our neighbors to the north in Canada can expect their allocation of Grenadiers to arrive in early 2024.

In summary, the Ineos Grenadier is more than just another SUV; it's a testament to Ineos' vision, investment, and commitment to quality. As the first batch makes its way to the U.S., it marks the beginning of a new chapter in the American automotive landscape, one that many are eagerly awaiting.

Kentucky's New Battery Recycling Facility Strengthens Its Position in the EV Sector

A Groundbreaking Partnership

Kentucky is set to become a major player in the electric vehicle (EV) sector with the announcement of a new battery recycling facility. This $65 million venture is a collaboration between U.S.-based Ascend Elements and South Korea-based SK ecoplant, along with its electronic-waste recycling subsidiary, TES. The facility will be built in Hopkinsville, Kentucky, and is expected to create about 60 jobs. Construction is slated to begin in November and is projected to be completed by January 2025.

The Scope of the Project

The 100,000-square-foot facility aims to recycle approximately 24,000 metric tons of used EV batteries and gigafactory scrap per year. That translates to around 56,000 EV batteries annually. The facility will disassemble and shred these batteries to produce 'black mass,' a powder containing valuable cathode and anode materials. This black mass will then supply Ascend Elements' nearby Apex 1 engineered battery materials facility, a $1 billion project currently under construction.

Financial Backing and Ownership

The financial aspect of this project is noteworthy. SK ecoplant will be the majority owner, holding a 64% stake, while Ascend Elements will own 25%, and TES will own the remaining 11%. Ascend Elements recently closed a $542 million funding round and received $480 million in U.S. Department of Energy grant awards to accelerate the construction of the Apex 1 project.

Kentucky: The New EV Hub

Kentucky Governor Andy Beshear highlighted that the state has attracted nearly $11 billion in private-sector investments and more than 10,000 jobs in the EV sector during his term. This new facility will further deepen Kentucky's connections to the emerging EV sector, making it a significant hub for EV technology in the United States.

The Bigger Picture

This facility is not just a standalone project but part of a larger ecosystem aimed at supporting the EV industry. It will play a crucial role in recycling end-of-life batteries and manufacturing scrap, thereby contributing to a more sustainable and circular economy in the EV sector.

U.S. New Vehicle Sales Surge in September Despite Challenges

A Resilient Market

According to a report by Cox Automotive, U.S. new vehicle sales are set to rise significantly in September compared to the same month last year. Sales volumes are expected to reach nearly 1.3 million units, marking an increase of more than 13% year-over-year. This growth comes despite several challenges, including rising interest rates on new vehicle loans and ongoing labor strikes by the United Auto Workers (UAW) union against major U.S. automakers like Ford, General Motors, and Stellantis.

Inventory Levels and Demand

One of the key factors contributing to this surge is the increase in industry-wide inventory levels, which have risen by more than 63%. Charlie Chesbrough, Cox Automotive's senior economist, attributes the robust sales to pent-up demand. Both individual consumers and large fleets have become active buyers as inventory availability has improved.

Revised Sales Forecast

Cox Automotive has also revised its full-year new-vehicle sales forecast upwards. The firm now expects sales to be between 15.3 million and 15.4 million units, up from the previous estimate of 15 million units. This upward revision indicates a strong outlook for the U.S. automotive market, even as it navigates through labor strikes and supply chain issues.

Labor Strikes and Supply Chain

The ongoing labor strikes involving the UAW and major U.S. automakers have posed a threat to the supply of newer models. Despite these challenges, the market has shown resilience, and the sales figures are a testament to that strength.

The Eyes as Health Indicators: More Than Meets the Eye

When it comes to health, your eyes serve as more than just a medium for vision; they act as revealing windows into your overall well-being. Various health conditions can manifest in your eyes, sometimes even before you experience any noticeable symptoms. Let's delve into how your eyes can be the tell-tale signs of conditions ranging from heart disease and high blood pressure to diabetes and autoimmune disorders.

Heart Disease

Interestingly, the eyes offer a unique vantage point for doctors to observe your blood vessels in real-time without the need for invasive procedures. Conditions such as high blood pressure, elevated cholesterol levels, and even the risk of stroke can be identified through a comprehensive eye exam. A retinal scan can expose decreased blood flow stemming from heart disease, which can lead to retinal damage.

High Blood Pressure

The impact of high blood pressure isn't limited to your heart; it extends to your eyes as well. Elevated blood pressure can contribute to eye conditions like glaucoma and macular degeneration. An eye exam can provide insights into how high blood pressure is affecting your ocular blood vessels.


The eyes are often the first place where signs of diabetes become evident. Elevated blood sugar levels can result in conditions like diabetic retinopathy, characterized by the swelling, leaking, or closure of blood vessels in the eyes. Given that diabetic retinopathy is a leading cause of vision loss, regular retinal scans are essential for diabetes management.

Autoimmune and Genetic Conditions

Autoimmune disorders such as rheumatoid arthritis, lupus, and multiple sclerosis can also manifest in your eyes. For example, approximately 30% of individuals with lupus experience dry eyes. Early detection through eye exams can facilitate better management of these conditions.

Vitamin Deficiency

A lack of Vitamin A can result in symptoms like night blindness and dry eyes. While this deficiency is less prevalent in developed countries, it's still a concern for those with liver disorders or issues with vitamin absorption.

Screen Time

While not directly harmful, excessive screen time can lead to eye strain, characterized by symptoms like dry eyes and headaches. This can further disrupt your sleep patterns and overall well-being.

Other Health Conditions

Even bacterial and viral infections can show up in your eyes. Conditions like conjunctivitis, commonly known as pink eye, can be triggered by respiratory viruses or even sexually transmitted infections.


Regular eye check-ups are not solely for the purpose of vision correction. They serve as a crucial tool for monitoring your overall health, revealing conditions you might otherwise be unaware of and allowing for early intervention and better management.

Navigating the Complex Landscape of Macular Degeneration

Macular degeneration is a condition that can be overwhelming to understand, especially when you're newly diagnosed. Dr. Aleksandra Rachitskaya, an ophthalmologist and retina specialist, sheds light on this eye condition that primarily affects people over the age of 50. The condition exists in two forms: wet and dry.

Dry Macular Degeneration

Dry macular degeneration is the more prevalent form, accounting for about 90% of all cases. It occurs when protein deposits, known as drusen, accumulate in the macula, the central part of the retina responsible for detailed vision. The condition progresses in stages, from no vision impact to a complete loss of central vision in its advanced form, known as geographic atrophy. However, not everyone will experience this progression. Lifestyle changes like taking specific vitamins, following a Mediterranean diet, and avoiding tobacco smoke can slow down the condition's progression.

Wet Macular Degeneration

Wet macular degeneration is less common but more severe. It arises when abnormal blood vessels grow under the retina, causing fluid accumulation and bleeding. Unlike its dry counterpart, wet macular degeneration is always considered advanced and directly impacts central vision. Treatment options include anti-VEGF injections that control the growth of new blood vessels, offering a ray of hope for preserving, and in some cases, improving vision.

The Importance of Early Intervention

Regardless of the type, early diagnosis and treatment are crucial. Regular eye check-ups can catch the condition in its initial stages, making it more manageable. Dr. Rachitskaya emphasizes the importance of annual eye exams and immediate consultation if you experience any new visual symptoms.


September has been a month filled with significant developments in both the automotive and eye health sectors. We've seen how Ineos is making strides in the U.S. market, the transformative steps Porsche is taking towards electric vehicles, and the importance of eye health as a window into our overall well-being. Special thanks to CarBuzz, Auto News, Reuters, ABC News, PR Newswire, Yahoo Finance, The New York Times,, and the Cleveland Clinic for providing the in-depth articles and studies that made this roundup possible. As we move into October, we look forward to bringing you more updates that drive us forward, both on the road and in healthcare.